Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Dose may be increased to 7.2 mg subcutaneously once weekly on patients who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated
Autophagy in cardiovascular aging
Behavioral interventions alone rarely achieve more than 5-10% sustained weight loss, while tirzepatide consistently produces 15-23% reduction in clinical trials
This level of convenience means no extra trips to a clinic and fewer opportunities for dosing errors
US$ 21.94
US$ 27.45
US$ 20.17
US$ 29.20
US$ 22.68
US$ 28.69
